Figure 5From: Dynamic analysis of CD127 expression on memory CD8 T cells from patients with chronic hepatitis B during telbivudine treatmentThe emergence of CD127 hepatitis B virus (HBV)-specific CD8+ T cells after successful antiviral treatment. Surface staining of HBV-specific CD8 T cells was performed using a HBV multimer [A. HBV Core 18-27 (FLPSDFFPSV), B. HBV Core 18-27 (FLPSDFFPSI)] and antibody to CD127, as described in the Materials and Methods. Data are shown as the percentage of multimer-positive CD8 T cells from 6 well responders (black bar) and 4 non responders (white bar) of CHB patients treated with telbivudine at 0 and 48 weeks respectively. (*P < 0.05).Back to article page